Dublin, Dec. 18, 2018 (GLOBE NEWSWIRE) — The “Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) – Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.
The global cell viability assays market is projected to grow at a CAGR of 8.4%.
The cell viability assays market is expected to reach USD 4.16 billion by 2023 from an estimated USD 2.78 billion in 2018, at a CAGR of 8.4%. The rising incidence and prevalence of chronic and infectious diseases, growing availability of funds for research and rising demand for cell-based assays in research, and increasing focus on the development of cell-based therapeutics are the key drivers for market growth. However, the high cost of instruments is expected to restrain the growth of this market to a certain extent during the forecast period.
The human cells segment to witness the highest growth during the forecast period.
On the basis of cell type, the cell viability assays market is segmented into human cells, animal cells, and microbial cells. The human cells segment is expected to register the highest CAGR during the forecast period. Growth in this segment is mainly due to the growing investments by government bodies and private sector organizations in research activities that are focused on developing new treatments for various human diseases.
The stem cell research applications segment to witness the highest growth during the forecast period.
On the basis of application, the cell viability assays market is segmented into drug discovery & development, basic research, stem cell research, clinical & diagnostic applications, and other applications. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research.
APAC is projected to witness the highest growth during the forecast period.
North America is expected to account for the largest share of the global cell viability assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.
Key Topics Covered
1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Sources
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Sources
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Market Share Estimation
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Cell Viability Assays Market Overview
4.2 Cell Viability Assays Market: Geographic Overview (2017)
4.3 Regional Mix: Cell Viability Assays Market (2018-2023)
4.4 Asia Pacific: Cell Viability Assays Market, By End User & Country (2017)
4.5 Cell Viability Assays Market: Developed vs Developing Markets
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence and Prevalence of Chronic and Infectious Diseases
5.2.1.2 Growing Availability of Funds for Research
5.2.1.3 Rising Demand for Cell-Based Assays in Research
5.2.1.4 Increasing Focus on the Development of Cell-Based Therapeutics
5.2.2 Restraint
5.2.2.1 High Cost of Instruments
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Growing Focus on Stem Cell Research
6 Cell Viability Assays Market, By Product
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.2 Assay Kits
6.2.2.1 Tetrazolium Reduction Assay Kits
6.2.2.1.1 Mtt Assay Kits
6.2.2.1.2 Other Tetrazolium Assay Kits
6.2.2.2 Resazurin Cell Viability Assay Kits
6.2.2.3 Calcein-Am Cell Viability Assay Kits
6.2.2.4 Other Assay Kits
6.2.3 Microplates
6.3 Instruments
6.3.1 Automated Cell Counters
6.3.2 Flow Cytometers
6.3.3 Spectrophotometers
6.3.4 Cell Imaging & Analysis Systems
7 Cell Viability Assays Market, By Cell Type
7.1 Introduction
7.2 Human Cells
7.3 Animal Cells
7.4 Microbial Cells
8 Cell Viability Assays Market, By Application
8.1 Introduction
8.2 Drug Discovery and Development
8.3 Basic Research
8.4 Stem Cell Research
8.5 Clinical and Diagnostic Applications
8.6 Other Applications
9 Cell Viability Assays Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Hospital & Diagnostic Laboratories
9.5 Other End Users
10 Cell Viability Assays Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 UK
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin America
10.6 Middle East & Africa
11 Competitive Landscape
11.1 Overview
11.2 Market Share Analysis
11.2.1 Market Share Analysis: Cell Viability Assay Kits Market
11.3 Competitive Situation and Trends
11.3.1 Product Launches
11.3.2 Expansions
11.3.3 Acquisitions
11.3.4 Other Strategies
12 Company Profiles
12.1 Thermo Fisher Scientific
12.2 Merck KGaA
12.3 Bio-Rad Laboratories
12.4 GE Healthcare
12.5 Danaher Corporation
12.6 Becton, Dickinson and Company
12.7 Promega Corporation
12.8 Biotium
12.9 Abcam PLC
12.10 Creative Bioarray
12.11 Biotek Instruments
12.12 Perkinelmer
For more information about this report visit https://www.researchandmarkets.com/research/8n529h/the_worldwide?w=12
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Laboratory Testing
